|
WO2021028768A1
|
|
METHOD FOR ALTERING THERAPY OF ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS BASED ON ANALYSIS OF ctDNA
|
|
WO2020174406A1
|
|
Method for quantifying the amount of a target sequence in a nucleic acid sample
|
|
WO2020121206A1
|
|
Method for quantifying gene fusion dna
|
|
WO2020049485A1
|
|
Method of treating a cancer patient without the need for a tissue biopsy
|
|
CA3107376A1
|
|
Method of sequencing using variable replicate multiplex pcr
|
|
US2021040564A1
|
|
Method for predicting and monitoring response to an immune checkpoint inhibitor
|
|
WO2019207439A1
|
|
Method for predicting and monitoring response to an immune checkpoint inhibitor
|
|
US2019112645A1
|
|
Method for measuring mutational load
|
|
GB201811520D0
|
|
Methods for enriching target nucleic acids
|
|
US10329627B1
|
|
Method for predicting and monitoring response to an immune checkpoint inhibitor
|
|
GB201807186D0
|
|
Method for predicting and monitoring response to an immune checkpoint inhibitor
|
|
GB201804641D0
|
|
Methods of sequencing nucleic acids and error correction of sequence reads
|
|
GB201804642D0
|
|
Methods of labelling nucleic acids
|
|
GB201711381D0
|
|
Methods for enriching target nucleic acids
|
|
GB201709675D0
|
|
Method for detecting genomic rearrangements
|
|
GB201615486D0
|
|
Methods for labelling nucleic acids
|
